Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.
2.

Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation.

Yang M, Birnbaum MJ, MacKay CA, Mason-Savas A, Thompson B, Odgren PR.

J Cell Physiol. 2008 May;215(2):497-505.

3.

DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Wisitrasameewong W, Kajiya M, Movila A, Rittling S, Ishii T, Suzuki M, Matsuda S, Mazda Y, Torruella MR, Azuma MM, Egashira K, Freire MO, Sasaki H, Wang CY, Han X, Taubman MA, Kawai T.

J Dent Res. 2017 Jun;96(6):685-693. doi: 10.1177/0022034517690490. Epub 2017 Feb 15.

PMID:
28199142
4.

Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).

Chiu YH, Mensah KA, Schwarz EM, Ju Y, Takahata M, Feng C, McMahon LA, Hicks DG, Panepento B, Keng PC, Ritchlin CT.

J Bone Miner Res. 2012 Jan;27(1):79-92. doi: 10.1002/jbmr.531.

5.

RANKL-induced DC-STAMP is essential for osteoclastogenesis.

Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H.

J Exp Med. 2004 Oct 4;200(7):941-6. Epub 2004 Sep 27.

6.

Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.

Herbert BA, Valerio MS, Gaestel M, Kirkwood KL.

PLoS One. 2015 May 6;10(5):e0125387. doi: 10.1371/journal.pone.0125387. eCollection 2015.

7.

Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology.

Witwicka H, Hwang SY, Reyes-Gutierrez P, Jia H, Odgren PE, Donahue LR, Birnbaum MJ, Odgren PR.

PLoS One. 2015 Jun 4;10(6):e0128275. doi: 10.1371/journal.pone.0128275. eCollection 2015.

8.

MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation.

Dou C, Zhang C, Kang F, Yang X, Jiang H, Bai Y, Xiang J, Xu J, Dong S.

Biochim Biophys Acta. 2014 Nov;1839(11):1084-96. doi: 10.1016/j.bbagrm.2014.08.002. Epub 2014 Aug 11.

PMID:
25123438
9.

NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).

Kim K, Lee SH, Ha Kim J, Choi Y, Kim N.

Mol Endocrinol. 2008 Jan;22(1):176-85. Epub 2007 Sep 20.

10.

Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression.

Kim HJ, Hong J, Jung JW, Kim TH, Kim JA, Kim YH, Kim SY.

Int Immunopharmacol. 2010 Nov;10(11):1440-7. doi: 10.1016/j.intimp.2010.08.017. Epub 2010 Sep 8.

PMID:
20831919
11.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

12.

Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells.

Kameyama S, Yoshimura Y, Kameyama T, Kikuiri T, Matsuno M, Deyama Y, Suzuki K, Iida J.

Int J Mol Med. 2013 Feb;31(2):292-8. doi: 10.3892/ijmm.2012.1220. Epub 2012 Dec 21.

PMID:
23292096
13.

RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.

Sankar U, Patel K, Rosol TJ, Ostrowski MC.

J Bone Miner Res. 2004 Aug;19(8):1339-48. Epub 2004 Mar 29.

14.

Regulators of osteoclast differentiation and cell-cell fusion.

Miyamoto T.

Keio J Med. 2011;60(4):101-5. Review.

15.

Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.

Koskinen C, Persson E, Baldock P, Stenberg Å, Boström I, Matozaki T, Oldenborg PA, Lundberg P.

J Biol Chem. 2013 Oct 11;288(41):29333-44. doi: 10.1074/jbc.M113.494591. Epub 2013 Aug 29.

16.

Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca2+ /NFATc1 Axis.

Chiu YH, Schwarz E, Li D, Xu Y, Sheu TR, Li J, de Mesy Bentley KL, Feng C, Wang B, Wang JC, Albertorio-Saez L, Wood R, Kim M, Wang W, Ritchlin CT.

J Cell Physiol. 2017 Sep;232(9):2538-2549. doi: 10.1002/jcp.25638. Epub 2017 Apr 12.

PMID:
27723141
17.

Blocking of sodium and potassium ion-dependent adenosine triphosphatase-α1 with ouabain and vanadate suppresses cell-cell fusion during RANKL-mediated osteoclastogenesis.

Makihira S, Nikawa H, Kajiya M, Kawai T, Mine Y, Kosaka E, Silva MJ, Tobiume K, Terada Y.

Eur J Pharmacol. 2011 Nov 30;670(2-3):409-18. doi: 10.1016/j.ejphar.2011.08.044. Epub 2011 Sep 14.

PMID:
21945676
18.

Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1.

Zhu M, Van Dyke TE, Gyurko R.

FASEB J. 2013 Aug;27(8):3344-53. doi: 10.1096/fj.12-220228. Epub 2013 Apr 29.

19.

Sulforaphene attenuates multinucleation of pre-osteoclasts by suppressing expression of cell-cell fusion-associated genes DC-STAMP, OC-STAMP, and Atp6v0d2.

Takagi T, Inoue H, Takahashi N, Katsumata-Tsuboi R, Uehara M.

Biosci Biotechnol Biochem. 2017 Jun;81(6):1220-1223. doi: 10.1080/09168451.2017.1281729. Epub 2017 Jan 30.

PMID:
28136694
20.

Luman is involved in osteoclastogenesis through the regulation of DC-STAMP expression, stability and localization.

Kanemoto S, Kobayashi Y, Yamashita T, Miyamoto T, Cui M, Asada R, Cui X, Hino K, Kaneko M, Takai T, Matsuhisa K, Takahashi N, Imaizumi K.

J Cell Sci. 2015 Dec 1;128(23):4353-65. doi: 10.1242/jcs.176057. Epub 2015 Oct 26.

Supplemental Content

Support Center